323 related articles for article (PubMed ID: 22665374)
1. Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.
Nakamura K; Kohda T; Shibata Y; Tsukamoto K; Arimitsu H; Hayashi M; Mukamoto M; Sasakawa N; Kozaki S
Infect Immun; 2012 Aug; 80(8):2886-93. PubMed ID: 22665374
[TBL] [Abstract][Full Text] [Related]
2. Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins.
Nakamura K; Kohda T; Seto Y; Mukamoto M; Kozaki S
Vet Microbiol; 2013 Mar; 162(2-4):881-890. PubMed ID: 23206412
[TBL] [Abstract][Full Text] [Related]
3. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
Tsukamoto K; Kohda T; Mukamoto M; Takeuchi K; Ihara H; Saito M; Kozaki S
J Biol Chem; 2005 Oct; 280(42):35164-71. PubMed ID: 16115873
[TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.
Peng L; Berntsson RP; Tepp WH; Pitkin RM; Johnson EA; Stenmark P; Dong M
J Cell Sci; 2012 Jul; 125(Pt 13):3233-42. PubMed ID: 22454523
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the unique ganglioside and cell membrane recognition mechanism of botulinum neurotoxin DC.
Zhang S; Berntsson RP; Tepp WH; Tao L; Johnson EA; Stenmark P; Dong M
Nat Commun; 2017 Nov; 8(1):1637. PubMed ID: 29158482
[TBL] [Abstract][Full Text] [Related]
6. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .
Karalewitz AP; Kroken AR; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
Biochemistry; 2010 Sep; 49(37):8117-26. PubMed ID: 20731382
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
J Biol Chem; 2012 Nov; 287(48):40806-16. PubMed ID: 23027864
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a novel botulinum neurotoxin.
Zhang S; Masuyer G; Zhang J; Shen Y; Lundin D; Henriksson L; Miyashita SI; MartÃnez-Carranza M; Dong M; Stenmark P
Nat Commun; 2017 Aug; 8():14130. PubMed ID: 28770820
[TBL] [Abstract][Full Text] [Related]
9. P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D/C mosaic neurotoxins.
Tsukamoto K; Arimitsu H; Ochi S; Nakamura K; Tanaka Y; Nuemket N; Taniguchi K; Kozaki S; Tsuji T
Microbiol Immunol; 2012 Oct; 56(10):664-72. PubMed ID: 22738015
[TBL] [Abstract][Full Text] [Related]
10. Preliminary X-ray crystallographic study of the receptor-binding domain of the D/C mosaic neurotoxin from Clostridium botulinum.
Nuemket N; Tanaka Y; Tsukamoto K; Tsuji T; Nakamura K; Kozaki S; Yao M; Tanaka I
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 May; 66(Pt 5):608-10. PubMed ID: 20445271
[TBL] [Abstract][Full Text] [Related]
11. Synaptotagmin Binding to Botulinum Neurotoxins.
MartÃnez-Carranza M; Blasco P; Gustafsson R; Dong M; Berntsson RP; Widmalm G; Stenmark P
Biochemistry; 2020 Feb; 59(4):491-498. PubMed ID: 31809018
[TBL] [Abstract][Full Text] [Related]
12. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S
Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.
Willjes G; Mahrhold S; Strotmeier J; Eichner T; Rummel A; Binz T
Biochemistry; 2013 Jun; 52(22):3930-8. PubMed ID: 23647335
[TBL] [Abstract][Full Text] [Related]
14. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.
Kroken AR; Karalewitz AP; Fu Z; Kim JJ; Barbieri JT
J Biol Chem; 2011 Jul; 286(30):26828-37. PubMed ID: 21632541
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins.
Kozaki S; Kamata Y; Watarai S; Nishiki T; Mochida S
Microb Pathog; 1998 Aug; 25(2):91-9. PubMed ID: 9712688
[TBL] [Abstract][Full Text] [Related]
16. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
Pellett S; Tepp WH; Scherf JM; Johnson EA
PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
[TBL] [Abstract][Full Text] [Related]
18. Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly.
Sun S; Suresh S; Liu H; Tepp WH; Johnson EA; Edwardson JM; Chapman ER
Cell Host Microbe; 2011 Sep; 10(3):237-47. PubMed ID: 21925111
[TBL] [Abstract][Full Text] [Related]
19. Botulinum neurotoxin detection and differentiation by mass spectrometry.
Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin X lacks potency in mice and in human neurons.
Gregg BM; Matsumura T; Wentz TG; Tepp WH; Bradshaw M; Stenmark P; Johnson EA; Fujinaga Y; Pellett S
mBio; 2024 Mar; 15(3):e0310623. PubMed ID: 38347673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
